0001354488-13-002288.txt : 20130429
0001354488-13-002288.hdr.sgml : 20130427
20130429172334
ACCESSION NUMBER: 0001354488-13-002288
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20051231
FILED AS OF DATE: 20130429
DATE AS OF CHANGE: 20130429
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIRSCHWEILER THOMAS
CENTRAL INDEX KEY: 0001273547
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-18170
FILM NUMBER: 13793247
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
issuerdirect_section16.xml
PRIMARY DOCUMENT
X0306
4
2005-12-31
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001273547
GIRSCHWEILER THOMAS
C/O BIOLIFE SOLUTIONS, INC.
3303 MONTE VILLA PARKWAY
BOTHELL
WA
98021
1
1
Common Shares
2005-12-31
4
P
0
1761827
0.12
A
2299887
D
Common Shares
2006-05-01
4
P
0
479999
0.06
A
13989886
D
Common Shares
2007-02-13
4
J
0
416666
0
A
14406552
D
Common Share Warrants
0.07
2010-11-29
4
J
0
1000000
0
A
2010-11-29
2015-11-29
Common Shares
1000000
1000000
D
Common Share Warrants
0.063
2011-08-10
4
J
0
1000000
0
A
2011-08-10
2016-08-30
Common Shares
1000000
1000000
D
Resulting purchase from cash dividends paid to Series G preferred stockholders; purchase price based on December 31, 2005 closing price of Issuer?s common shares.
Resulting purchase from cash dividend paid to Series G preferred stockholders; purchase price based on May 1, 2006 closing price of Issuer's common shares.
Total includes 11,210,000 common shares acquired upon conversion of Series F and Series G preferred shares and warrants previously reported on Form 4 filed on April 18, 2006 and 538,060 common shares previously held.
Shares of common stock issued to reporting person in connection with financing costs related to Secured Multi-Draw Term Loan Facility Agreement in the amount of $2,000,000, with a maturity date of January 11, 2010.
Warrants acquired as consideration for an amendment to the issuer's Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person's "Facility?" to $4,750,000 and extending the maturity date to January 11, 2013.
Warrants acquired as consideration for an amendment to the issuer's Secured Multi-Draw Term Loan Facility Agreement, increasing the reporting person's "Facility"? to $5,250,000.
/s/ Thomas Girschweiler
2013-04-29